Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk

Author： Janero David R   Lindsley Loren   Vemuri Venkata Kiran   Makriyannis Alexandros  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.6, Iss.10, 2011-10, pp. : 995-1025

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Hot Topic: G Protein-Coupled Receptor Biased Agonism: Development Towards Future Selective Therapeutics)

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 9, 2012-08 ,pp. : 803-803

Bentham Science Publishers

Access to resources Recommend Favorite

Fluorescent Agonists and Antagonists for Vasopressin/Oxytocin G Protein-Coupled Receptors: Usefulness in Ligand Screening Assays and Receptor Studies

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 10, 2008-09 ,pp. : 996-1005

Bentham Science Publishers

Access to resources Recommend Favorite

G-Protein Coupled Receptor Antagonists-1: Protease Activated Receptor-1 (PAR-1) Antagonists as Novel Cardiovascular Therapeutic Agents (Hot Topic: Structure and property Approaches in Recent Drug Discovery Guest Editor: Guo Zhu Zheng)

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 10, 2003-06 ,pp. : 1115-1123

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of G Protein-Coupled Receptor Kinases by Phospholipids

By  

Current Medicinal Chemistry, Vol. 20, Iss. 1, 2013-01 ,pp. : 39-46

Bentham Science Publishers

Access to resources Recommend Favorite

Partial agonists and G protein-coupled receptor desensitization

By Clark R.B.   Knoll B.J.   Barber R.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 7, 1999-07 ,pp. : 279-286

Elsevier

Access to resources Recommend Favorite